Unity Biotechnology Stock Probability of Future Stock Price Finishing Over 3.68
| UBX Stock | USD 1.24 0.03 2.48% |
Unity |
Unity Biotechnology Target Price Odds to finish over 3.68
The tendency of Unity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 3.68 or more in 90 days |
| 1.24 | 90 days | 3.68 | close to zero percent |
Based on a normal probability distribution, the odds of Unity Biotechnology to move over $ 3.68 or more in 90 days from now is close to zero percent (This Unity Biotechnology probability density function shows the probability of Unity Stock to fall within a particular range of prices over 90 days) . Probability of Unity Biotechnology price to stay between its current price of $ 1.24 and $ 3.68 at the end of the 90-day period is about 85.92 .
Considering the 90-day investment horizon Unity Biotechnology has a beta of 0.41. This usually implies as returns on the market go up, Unity Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Unity Biotechnology will be expected to be much smaller as well. Additionally Unity Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Unity Biotechnology Price Density |
| Price |
Predictive Modules for Unity Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Unity Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Unity Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Unity Biotechnology is not an exception. The market had few large corrections towards the Unity Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Unity Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Unity Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | -0.23 |
Unity Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Unity Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Unity Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Unity Biotechnology generated a negative expected return over the last 90 days | |
| Unity Biotechnology may become a speculative penny stock | |
| Unity Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (39.86 M) with loss before taxes, overhead, and interest of (35.22 M). | |
| Unity Biotechnology has about 64.51 M in cash with (37.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Unity Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Alyeska Investment Group L.P.s Strategic Acquisition in Unity Biotechnology Inc |
Unity Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Unity Stock often depends not only on the future outlook of the current and potential Unity Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Unity Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.8 M | |
| Cash And Short Term Investments | 43.2 M |
Unity Biotechnology Technical Analysis
Unity Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Unity Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Unity Biotechnology. In general, you should focus on analyzing Unity Stock price patterns and their correlations with different microeconomic environments and drivers.
Unity Biotechnology Predictive Forecast Models
Unity Biotechnology's time-series forecasting models is one of many Unity Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Unity Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Unity Biotechnology
Checking the ongoing alerts about Unity Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Unity Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Unity Biotechnology generated a negative expected return over the last 90 days | |
| Unity Biotechnology may become a speculative penny stock | |
| Unity Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (39.86 M) with loss before taxes, overhead, and interest of (35.22 M). | |
| Unity Biotechnology has about 64.51 M in cash with (37.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Unity Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Alyeska Investment Group L.P.s Strategic Acquisition in Unity Biotechnology Inc |
Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.